Summary

Digital Biomarkers Market – Scope of Report
TMR’s report on the global digital biomarkers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global digital biomarkers market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global digital biomarkers market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the digital biomarkers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global digital biomarkers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global digital biomarkers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global digital biomarkers market.

The report delves into the competitive landscape of the global digital biomarkers market. Key players operating in the global digital biomarkers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global digital biomarkers market profiled in this report.

Key Questions Answered in Global digital biomarkers Market Report
• What is the sales/revenue generated by digital biomarkers across all regions during the forecast period?
• What are the opportunities in the global digital biomarkers market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Digital Biomarkers Market – Research Objectives and Research Approach
The comprehensive report on the global digital biomarkers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global digital biomarkers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global digital biomarkers market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Digital Biomarkers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Digital Biomarkers Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Digital Biomarkers Market Analysis and Forecast, by Component
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Component, 2020-2034
6.3.1. Biosensors
6.3.2. Wearables
6.3.3. Smartphones & Smartwatches
6.3.4. Others (Implantables, etc.)
6.4. Market Attractiveness Analysis, by Component
7. Global Digital Biomarkers Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Cardiovascular
7.3.2. Sleep and Movement Disorder
7.3.3. Pain Management
7.3.4. Gastrointestinal
7.3.5. Neurodegenerative
7.3.6. Diabetic
7.3.7. Others (Pulmonary, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global Digital Biomarkers Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Healthcare Companies
8.3.2. Healthcare Providers
8.3.3. Payers
8.3.4. Others (Patients, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Digital Biomarkers Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Digital Biomarkers Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Component, 2020-2034
10.3.1. Biosensors
10.3.2. Wearables
10.3.3. Smartphones & Smartwatches
10.3.4. Others (Implantables, etc.)
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Cardiovascular
10.4.2. Sleep and Movement Disorder
10.4.3. Pain Management
10.4.4. Gastrointestinal
10.4.5. Neurodegenerative
10.4.6. Diabetic
10.4.7. Others (Pulmonary, etc.)
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Healthcare Companies
10.5.2. Healthcare Providers
10.5.3. Payers
10.5.4. Others (Patients, etc.)
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Component
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Digital Biomarkers Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Component, 2020-2034
11.3.1. Biosensors
11.3.2. Wearables
11.3.3. Smartphones & Smartwatches
11.3.4. Others (Implantables, etc.)
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Cardiovascular
11.4.2. Sleep and Movement Disorder
11.4.3. Pain Management
11.4.4. Gastrointestinal
11.4.5. Neurodegenerative
11.4.6. Diabetic
11.4.7. Others (Pulmonary, etc.)
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Healthcare Companies
11.5.2. Healthcare Providers
11.5.3. Payers
11.5.4. Others (Patients, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Component
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Digital Biomarkers Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Component, 2020-2034
12.3.1. Cardiovascular
12.3.2. Sleep and Movement Disorder
12.3.3. Pain Management
12.3.4. Gastrointestinal
12.3.5. Neurodegenerative
12.3.6. Diabetic
12.3.7. Others (Pulmonary, etc.)
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Healthcare Companies
12.4.2. Healthcare Providers
12.4.3. Payers
12.4.4. Others (Patients, etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Component
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Digital Biomarkers Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Component, 2020-2034
13.3.1. Biosensors
13.3.2. Wearables
13.3.3. Smartphones & Smartwatches
13.3.4. Others (Implantables, etc.)
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Cardiovascular
13.4.2. Sleep and Movement Disorder
13.4.3. Pain Management
13.4.4. Gastrointestinal
13.4.5. Neurodegenerative
13.4.6. Diabetic
13.4.7. Others (Pulmonary, etc.)
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Healthcare Companies
13.5.2. Healthcare Providers
13.5.3. Payers
13.5.4. Others (Patients, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Component
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Digital Biomarkers Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Component, 2020-2034
14.3.1. Biosensors
14.3.2. Wearables
14.3.3. Smartphones & Smartwatches
14.3.4. Others (Implantables, etc.)
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Cardiovascular
14.4.2. Sleep and Movement Disorder
14.4.3. Pain Management
14.4.4. Gastrointestinal
14.4.5. Neurodegenerative
14.4.6. Diabetic
14.4.7. Others (Pulmonary, etc.)
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Healthcare Companies
14.5.2. Healthcare Providers
14.5.3. Payers
14.5.4. Others (Patients, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Component
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. AliveCor Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Alphabet Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Bayer AG
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Biogen Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Evidation Health, Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Eli, Lilly and Company
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. GSK plc
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Novartis AG
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Pfizer Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview